Nuwellis (NUWE) Return on Capital Employed Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,776.00 |
| Dec 31, 2025 | -25,815.00 |
| Sep 30, 2025 | -10,492.00 |
| Jun 30, 2025 | -2,360.00 |
| Mar 31, 2025 | 15,169.00 |
| Dec 31, 2024 | 36,695.00 |
| Sep 30, 2024 | -5,183.00 |
| Jun 30, 2024 | -40,970.00 |
| Mar 31, 2024 | -24,394.00 |
| Dec 31, 2023 | -844.00 |
| Sep 30, 2023 | 17,068.00 |
| Jun 30, 2023 | 13,426.00 |
| Mar 31, 2023 | 9,033.00 |
| Dec 31, 2022 | 10,739.00 |
| Sep 30, 2022 | -9,668.00 |
| Jun 30, 2022 | -6,718.00 |
| Mar 31, 2022 | 633.00 |
| Dec 31, 2021 | 7,486.00 |
| Sep 30, 2021 | 24,976.00 |
| Jun 30, 2021 | 23,355.00 |
| Mar 31, 2021 | 14,786.00 |
| Dec 31, 2020 | 11,908.00 |
| Sep 30, 2020 | -7,755.00 |
| Jun 30, 2020 | -18,295.00 |
| Mar 31, 2020 | -28,574.00 |
| Dec 31, 2019 | -53,097.00 |
| Sep 30, 2019 | -20,367.00 |
| Jun 30, 2019 | -10,359.00 |
| Mar 31, 2019 | -13,033.00 |
| Dec 31, 2018 | -18,692.00 |
| Sep 30, 2018 | -16,150.00 |
| Jun 30, 2018 | -5,990.00 |
| Mar 31, 2018 | 1,634.00 |
| Dec 31, 2017 | -2,454.00 |
| Sep 30, 2017 | 18,461.00 |
| Jun 30, 2017 | 101,577.00 |
| Mar 31, 2017 | 34,412.00 |